HSKA News and Press, Heska Corporation From 02/23/23

Heska to Present at Three Upcoming Institutional Investor Conferences PR Newswire LOVELAND, Colo. , Feb. 23, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic a...

/C O R R E C T I O N -- Heska Corporation/ PR Newswire In the news release, Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023 , issued 08-Feb-2023 by Heska Corporation over PR Newswire, the conference call Unite...

Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023 PR Newswire LOVELAND, Colo. , Feb. 8, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of ad...

Heska Corporation Completes Acquisition of LightDeck Diagnostics PR Newswire LOVELAND, Colo. , Jan. 3, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA ; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty ...

Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference PR Newswire LOVELAND, Colo. , Dec. 23, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnos...

Heska press release ( NASDAQ: HSKA ): Q3 Non-GAAP EPS of $0.41 misses by $0.04 . Revenue of $61.5M (+2.1% Y/Y) misses by $6.6M . For further details see: Heska Non-GAAP EPS of $0.41 misses by $0.04, revenue of $61.5M misses by $6.6M

Heska Corporation Reports Third Quarter 2022 Results PR Newswire North America Point of Care Lab Consumables up 11.4%, Consolidated Gross Margin up 180 bps LOVELAND, Colo. , Nov. 8, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska"...

Volition Announces the Launch of the Nu.Q® Vet Cancer Screening Test in the U.S. and Europe Through Heska's Reference Laboratories PR Newswire HENDERSON, Nev. , Nov. 3, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a mul...

Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022 PR Newswire LOVELAND, Colo. , Oct. 18 , 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced...

Heska ( NASDAQ: HSKA ) to acquire 100% of the share capital of MBio Diagnostics, d/b/a LightDeck Diagnostics, an innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities. Heska will purchase Lig...